Why the study?
MINS is a frequent complication associated with perioperative mortality, but preventive measures, systematic surveillance approaches, and treatment standards are still lacking.
What are the current screening standards and preventive options to reduce the risk of myocardial injury after non-cardiac surgery (MINS)?
What are the current screening standards and preventive options to reduce the risk of myocardial injury after non-cardiac surgery (MINS)?
This narrative review highlights the critical need to identify patients at risk for MINS and summarizes modifiable perioperative strategies to mitigate the associated high risk of postoperative mortality.
Answers are grounded in this paper and cite their sources.
May inform perioperative MINS screening and optimization; leaves open validation in prospective trials.
Myocardial injury is a frequent complication of surgical patients after having non-cardiac surgery that is strongly associated with perioperative mortality. While intraoperative anesthesia-related deaths are exceedingly rare, about 1% of patients undergoing non-cardiac surgery die within the first 30 postoperative days. Given the number of surgeries performed annually, death following surgery is the second leading cause of death in the United States. Myocardial injury after non-cardiac surgery (MINS) is defined as an elevation in troponin concentrations within 30 days postoperatively. Although typically asymptomatic, patients with MINS suffer myocardial damage and have a 10% risk of death within 30 days after surgery and excess risks of mortality that persist during the first postoperative year. Many factors for the development of MINS are non-modifiable, such as preexistent coronary artery disease. Preventive measures, systematic approaches to surveillance and treatment standards are still lacking, however many factors are modifiable and should be considered in clinical practice: the importance of hemodynamic control, adequate oxygen supply, metabolic homeostasis, the use of perioperative medications such as statins, anti-thrombotic agents, beta-blockers, or anti-inflammatory agents, as well as some evidence regarding the choice of sedative and analgesic for anesthesia are discussed. Also, as age and complexity in comorbidities of the surgical patient population increase, there is an urgent need to identify patients at risk for MINS and develop prevention and treatment strategies. In this review, we provide an overview of current screening standards and promising preventive options in the perioperative setting and address knowledge gaps requiring further investigation.
No takes yet. Share an insight, caveat, or question.
Bello et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: